Background:
Although pharmacotherapy is critical to the medical care of older patients, medications can have considerable toxicity in this age group. To date, research has focused on inappropriate prescribing and policy efforts have aimed at access, but no comprehensive measurement of the quality of pharmacologic management using explicit criteria has been performed.
Objective:
To evaluate the broad range of pharmacologic care processes for vulnerable older patients.
Design:
Observational cohort study.
Setting:
2 managed care organizations enrolling older persons.
Patients:
Community-dwelling high-risk patients 65 years of age or older continuously enrolled in the managed care organizations from 1 July 1998 to 31 July 1999.
Measurements:
Patients' receipt of care as specified in 43 quality indicators covering 4 domains of pharmacologic care: 1) prescribing indicated medications; 2) avoiding inappropriate medications; 3) education, continuity, and documentation; and 4) medication monitoring.
Results:
Of 475 vulnerable older patients, 372 (78%) consented to participate and had medical records that could be abstracted. The percentage of appropriate pharmacologic management ranged from 10% for documentation of risks of nonsteroidal anti-inflammatory drugs to 100% for avoiding short-acting calcium-channel blockers in patients with heart failure and avoiding β-blockers in patients with asthma. Pass rates for quality indicators in the “avoiding inappropriate medications” domain (97% [95% CI, 96% to 98%]) were significantly higher than pass rates for “prescribing indicated medications” (50% [CI, 45% to 55%]); “education, continuity, and documentation” (81% [CI, 79% to 84%]); and “medication monitoring” (64% [CI, 60% to 68%]).
Limitations:
Fewer than 10 patients were eligible for many of the quality indicators measured, and the generalizability of these findings in 2 managed care organizations to the general geriatric population is uncertain.
Conclusions:
Failures to prescribe indicated medications, monitor medications appropriately, document necessary information, educate patients, and maintain continuity are more common prescribing problems than use of inappropriate drugs in older patients.
References
- 1. Health Care Use in America—1996 Medical Expenditure Panel Survey Highlights. Rockville, MD: Agency for Healthcare Research and Quality; 1996. Accessed at www.meps.ahrq.gov/papers/hl9_99-0029/hl9.htm#Fig1 on 9 March 2004. Google Scholar
- 2. Medical Expenditure Panel Survey—2000 Compendium of Tables. Household Medical Expenditures. Rockville, MD: Agency for Healthcare Research and Quality; 2000. Accessed at www.meps.ahrq.gov/CompendiumTables/00Ch2/Tbls1_9/TC00_2_All.pdf on 9 March 2004. Google Scholar
- 3.
Hanlon JT ,Schmader KE ,Koronkowski MJ ,Weinberger M ,Landsman PB ,Samsa GP ,et al . Adverse drug events in high risk older outpatients. J Am Geriatr Soc. 1997;45:945-8. [PMID:9256846 ] CrossrefMedlineGoogle Scholar - 4.
Schneider JK ,Mion LC ,Frengley JD . Adverse drug reactions in an elderly outpatient population. Am J Hosp Pharm. 1992;49:90-6. [PMID:1570873 ] MedlineGoogle Scholar - 5.
Chrischilles EA ,Segar ET ,Wallace RB . Self-reported adverse drug reactions and related resource use. A study of community-dwelling persons 65 years of age and older. Ann Intern Med. 1992;117:634-40. [PMID:1530194 ] LinkGoogle Scholar - 6.
Fink A ,Siu AL ,Brook RH ,Park RE ,Solomon DH . Assuring the quality of health care for older persons. An expert panel's priorities. JAMA. 1987;258:1905-8. [PMID:3656600 ] CrossrefMedlineGoogle Scholar - 7.
Sloss EM ,Solomon DH ,Shekelle PG ,Young RT ,Saliba D ,MacLean CH ,et al . Selecting target conditions for quality of care improvement in vulnerable older adults. J Am Geriatr Soc. 2000;48:363-9. [PMID:10798460 ] CrossrefMedlineGoogle Scholar - 8.
Miller DK ,Coe RM ,Romeis JC ,Morley JE . Improving quality of geriatric health care in four delivery sites: suggestions from practitioners and experts. J Am Geriatr Soc. 1995;43:60-5. [PMID:7806742 ] CrossrefMedlineGoogle Scholar - 9.
Fitzgerald LS ,Hanlon JT ,Shelton PS ,Landsman PB ,Schmader KE ,Pulliam CC ,et al . Reliability of a modified medication appropriateness index in ambulatory older persons. Ann Pharmacother. 1997;31:543-8. [PMID:9161645 ] CrossrefMedlineGoogle Scholar - 10.
Hanlon JT ,Schmader KE ,Samsa GP ,Weinberger M ,Uttech KM ,Lewis IK ,et al . A method for assessing drug therapy appropriateness. J Clin Epidemiol. 1992;45:1045-51. [PMID:1474400 ] CrossrefMedlineGoogle Scholar - 11.
Beers MH ,Ouslander JG ,Rollingher I ,Reuben DB ,Brooks J ,Beck JC . Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med. 1991;151:1825-32. [PMID:1888249 ] CrossrefMedlineGoogle Scholar - 12.
Beers MH . Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med. 1997;157:1531-6. [PMID:9236554 ] CrossrefMedlineGoogle Scholar - 13.
Fick DM ,Cooper JW ,Wade WE ,Waller JL ,Maclean JR ,Beers MH . Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163:2716-24. [PMID:14662625 ] CrossrefMedlineGoogle Scholar - 14.
Aparasu RR ,Fliginger SE . Inappropriate medication prescribing for the elderly by office-based physicians. Ann Pharmacother. 1997;31:823-9. [PMID:9220038 ] CrossrefMedlineGoogle Scholar - 15.
Aparasu RR ,Mort JR . Inappropriate prescribing for the elderly: beers criteria-based review. Ann Pharmacother. 2000;34:338-46. [PMID:10917382 ] CrossrefMedlineGoogle Scholar - 16.
Aparasu RR ,Sitzman SJ . Inappropriate prescribing for elderly outpatients. Am J Health Syst Pharm. 1999;56:433-9. [PMID:10096703 ] CrossrefMedlineGoogle Scholar - 17.
Willcox SM ,Himmelstein DU ,Woolhandler S . Inappropriate drug prescribing for the community-dwelling elderly. JAMA. 1994;272:292-6. [PMID:8028142 ] CrossrefMedlineGoogle Scholar - 18.
Zhan C ,Sangl J ,Bierman AS ,Miller MR ,Friedman B ,Wickizer SW ,et al . Potentially inappropriate medication use in the community-dwelling elderly: findings from the 1996 Medical Expenditure Panel Survey. JAMA. 2001;286:2823-9. [PMID:11735757 ] CrossrefMedlineGoogle Scholar - 19. Ratner J. Prescription Drugs and the Elderly: Many Still Receive Potentially Harmful Drugs Despite Recent Improvement. Washington, DC: U.S. General Accounting Office; 1995. Publication no. HEHS-95-152. Google Scholar
- 20.
Hanlon JT ,Fillenbaum GG ,Schmader KE ,Kuchibhatla M ,Horner RD . Inappropriate drug use among community-dwelling elderly. Pharmacotherapy. 2000;20:575-82. [PMID:10809345 ] CrossrefMedlineGoogle Scholar - 21.
Tamblyn RM ,McLeod PJ ,Abrahamowicz M ,Monette J ,Gayton DC ,Berkson L ,et al . Questionable prescribing for elderly patients in Quebec. CMAJ. 1994;150:1801-9. [PMID:8199957 ] MedlineGoogle Scholar - 22.
Wenger NS ,Solomon DH ,Roth CP ,MacLean CH ,Saliba D ,Kamberg CJ ,et al . The quality of medical care provided to vulnerable community-dwelling older patients. Ann Intern Med. 2003;139:740-7. [PMID:14597458 ] LinkGoogle Scholar - 23.
Shekelle PG ,MacLean CH ,Morton SC ,Wenger NS . ACOVE quality indicators. Ann Intern Med. 2001;135:653-67. [PMID:11601948 ] LinkGoogle Scholar - 24.
Wenger NS ,Shekelle PG . Assessing care of vulnerable elders: ACOVE project overview. Ann Intern Med. 2001;135:642-6. [PMID:11601946 ] LinkGoogle Scholar - 25.
Saliba D ,Elliott M ,Rubenstein LZ ,Solomon DH ,Young RT ,Kamberg CJ ,et al . The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc. 2001;49:1691-9. [PMID:11844005 ] CrossrefMedlineGoogle Scholar - 26.
Kane RL ,Ouslander JG ,Abrass IB . Essentials of Clinical Geriatrics. 3rd ed. New York: McGraw-Hill; 1994. Google Scholar - 27.
Rao JN ,Scott AJ . The analysis of cateogorical data from complex sample surveys: chi-squared tests for goodness of fit and independence in two-way tables. Journal of the American Statistical Association. 1981;76:221-9. CrossrefGoogle Scholar - 28.
Soumerai SB ,McLaughlin TJ ,Spiegelman D ,Hertzmark E ,Thibault G ,Goldman L . Adverse outcomes of underuse of beta-blockers in elderly survivors of acute myocardial infarction. JAMA. 1997;277:115-21. [PMID:8990335 ] CrossrefMedlineGoogle Scholar - 29.
Havranek EP ,Abrams F ,Stevens E ,Parker K . Determinants of mortality in elderly patients with heart failure: the role of angiotensin-converting enzyme inhibitors. Arch Intern Med. 1998;158:2024-8. [PMID:9778202 ] CrossrefMedlineGoogle Scholar - 30.
Berlowitz DR ,Ash AS ,Hickey EC ,Friedman RH ,Glickman M ,Kader B ,et al . Inadequate management of blood pressure in a hypertensive population. N Engl J Med. 1998;339:1957-63. [PMID:9869666 ] CrossrefMedlineGoogle Scholar - 31.
Hunt D ,Young P ,Simes J ,Hague W ,Mann S ,Owensby D ,et al . Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial. Ann Intern Med. 2001;134:931-40. [PMID:11352694 ] LinkGoogle Scholar - 32.
Primatesta P ,Poulter NR . Lipid concentrations and the use of lipid lowering drugs: evidence from a national cross sectional survey. BMJ. 2000;321:1322-5. [PMID:11090516 ] CrossrefMedlineGoogle Scholar - 33.
Gurwitz JH ,Col NF ,Avorn J . The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 1992;268:1417-22. [PMID:1512909 ] CrossrefMedlineGoogle Scholar - 34.
Heiat A ,Gross CP ,Krumholz HM . Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med. 2002;162:1682-8. [PMID:12153370 ] CrossrefMedlineGoogle Scholar - 35.
Redelmeier DA ,Tan SH ,Booth GL . The treatment of unrelated disorders in patients with chronic medical diseases. N Engl J Med. 1998;338:1516-20. [PMID:9593791 ] CrossrefMedlineGoogle Scholar - 36.
Rochon PA ,Gurwitz JH . Prescribing for seniors: neither too much nor too little. JAMA. 1999;282:113-5. [PMID:10411177 ] CrossrefMedlineGoogle Scholar - 37.
Tseng CW ,Brook RH ,Keeler E ,Mangione CM . Impact of an annual dollar limit or “cap” on prescription drug benefits for Medicare patients. JAMA. 2003;290:222-7. [PMID:12851277 ] CrossrefMedlineGoogle Scholar - 38. Laschober MA, Kitchman M, Neuman P, Strabic AA. Trends in Medicare supplemental insurance and prescription drug coverage, 1996-1999. Health Aff (Millwood). 2002;Supp Web Exclusives:W127-38. [PMID: 12703569] Google Scholar
- 39. Centers for Medicare & Medicaid Services. Medicare Current Beneficiary Survey. 2002. Accessed at www.cms.hhs.gov/mcbs/PublDT.asp on 20 November 2003. Google Scholar
- 40.
Luck J ,Peabody JW ,Dresselhaus TR ,Lee M ,Glassman P . How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. Am J Med. 2000;108:642-9. [PMID:10856412 ] CrossrefMedlineGoogle Scholar - 41.
Kahn KL ,Keeler EB ,Sherwood MJ ,Rogers WH ,Draper D ,Bentow SS ,et al . Comparing outcomes of care before and after implementation of the DRG-based prospective payment system. JAMA. 1990;264:1984-8. [PMID:2120477 ] CrossrefMedlineGoogle Scholar - 42.
Monane M ,Matthias DM ,Nagle BA ,Kelly MA . Improving prescribing patterns for the elderly through an online drug utilization review intervention: a system linking the physician, pharmacist, and computer. JAMA. 1998;280:1249-52. [PMID:9786375 ] CrossrefMedlineGoogle Scholar - 43.
Kuperman GJ ,Teich JM ,Gandhi TK ,Bates DW . Patient safety and computerized medication ordering at Brigham and Women's Hospital. Jt Comm J Qual Improv. 2001;27:509-21. [PMID:11593885 ] MedlineGoogle Scholar - 44.
Leape LL ,Bates DW ,Cullen DJ ,Cooper J ,Demonaco HJ ,Gallivan T ,et al . Systems analysis of adverse drug events. ADE Prevention Study Group. JAMA. 1995;274:35-43. [PMID:7791256 ] CrossrefMedlineGoogle Scholar - 45.
Teich JM ,Merchia PR ,Schmiz JL ,Kuperman GJ ,Spurr CD ,Bates DW . Effects of computerized physician order entry on prescribing practices. Arch Intern Med. 2000;160:2741-7. [PMID:11025783 ] CrossrefMedlineGoogle Scholar
Author, Article, and Disclosure Information
From the University of California, Los Angeles, and the Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, California; RAND Health, Santa Monica, California and Washington, DC; and Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Acknowledgments: The authors thank Robert Brook, MD, ScD, for his guidance and Patricia Smith and Victor Gonzalez for technical assistance.
Grant Support: By a contract from Pfizer Inc. to RAND. Dr. Shekelle is a Senior Research Associate of the Veterans Affairs Health Services Research and Development Service. Dr. Chang is supported by a National Research Service Award (PE-19001) and the University of California, Los Angeles, Specialty Training and Advanced Research (STAR) Program.
Disclosures:Stock ownership or options (other than mutual funds): Roy T. Young (Pfizer Inc.); Grants received: J. Avorn (Pfizer Inc., Bristol-Myers Squibb, Novo Nordisk, Pharmacia).
Corresponding Author: Takahiro Higashi, MD, Division of General Internal Medicine, University of California, Los Angeles, 911 Broxton Plaza, Los Angeles, CA 90095.
Current Author Addresses: Drs. Higashi and Chang: Division of General Internal Medicine, University of California, Los Angeles, 911 Broxton Plaza, Los Angeles, CA 90095-1736.
Dr. Shekelle: Greater Los Angeles Veterans Affairs Healthcare System, 11301 Wilshire Boulevard, Los Angeles, CA 90073.
Drs. Solomon, MacLean, Adams, and Wenger and Ms. Roth: RAND, 1700 Main Street, M-26, Santa Monica, CA 90407-2138.
Drs. Knight and Avorn: Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, 221 Longwood Avenue, Suite 341, Boston, MA 02115.
Ms. Kamberg: RAND, 1200 South Hayes Street, Arlington, VA 22202.
Dr. Young: Division of General Internal Medicine, University of California, Los Angeles, 200 Medical Plaza, Los Angeles, CA 90095-1736.
Dr. Reuben: Division of Geriatrics, University of California, Los Angeles, 200 Medical Plaza, Los Angeles, CA 90095-1736.
Submit a Comment
Contributors must reveal any conflict of interest. Comments are moderated. Please see our information for authorsregarding comments on an Annals publication.
*All comments submitted after October 1, 2021 and selected for publication will be published online only.